Treatment for multiple bilobar liver metastases of colorectal cancer
Authors:
- 1 December 2005
- journal article
- review article
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 391 (2) , 130-142
Abstract
Recent advances have extended indications for hepatectomy to include multiple bilobar colorectal liver metastases (CLM). Staging systems based on the biological malignancy of primary and metastatic tumors provide appropriate indications for hepatectomy in CLM. However, suitability for resection in patients with complex and extensive hepatic metastases is controversial. A medline search was performed to identify papers reporting the resection for CLM. Techniques, indication, and results were reviewed. If the anticipated remnant liver volume is small (25–40% of total), suggesting a high risk of postoperative liver failure, portal vein embolization (PVE) is recommended prior to hepatectomy. However, curative resections are not always possible. Specifically in synchronous multiple bilobar CLM, two-stage hepatectomy, comprising bilateral hepatectomy and primary resection with or without PVE, can prevent growth of ipsilateral metastatic nodules in the remnant liver and reduce surgical risk. Several local ablation techniques can complement surgery if hepatic resection alone increases the risk of postoperative liver failure or is not curative. Chemotherapy combined with targeted treatment can suppress recurrence and extend indications for hepatectomy by reducing the size and number of primary irresectable tumors. PVE or staged procedure combining with local ablation or neoadjuvant, downstaging or adjuvant therapies extends indications for hepatectomy to include multiple bilobar CLM. The 5-year survival rate for multiple bilobar CLM treated with alternating hepatectomy and chemotherapy is comparable to the values reported for single and hemilateral CLM.Keywords
This publication has 100 references indexed in Scilit:
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liverBritish Journal of Surgery, 2003
- Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastasesBritish Journal of Surgery, 2003
- Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancerBritish Journal of Cancer, 2002
- Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical marginBritish Journal of Surgery, 1997
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996
- Resection of colorectal liver metastasesWorld Journal of Surgery, 1995
- Adjuvante und palliative regionale Therapie von Lebermetastasen kolorektaler TumorenDMW - Deutsche Medizinische Wochenschrift, 1995
- A Multiple Regression Equation for Prediction of Posthepatectomy Liver FailureAnnals of Surgery, 1984